– Fifteen abstracts supporting Taltz®, Olumiant® and mirikizumab reveal new findings for the treatment of psoriasis and atopic dermatitis – Eli Lilly and Company (NYSE: LLY) announced that it will present new data for Taltz® (ixekizumab), Olumiant® (baricitinib) and mirikizumab at ...